{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:17:42Z","timestamp":1740460662650,"version":"3.37.3"},"reference-count":25,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publications.ersnet.org\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,9,10]]},"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1183\/13993003.01804-2024","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:31:01Z","timestamp":1735839061000},"page":"2401804","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Disarming the cavalry: targeting neutrophils to limit collateral damage in non-CF bronchiectasis"],"prefix":"10.1183","volume":"65","author":[{"given":"Omri A.","family":"Arbiv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley S.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"2025010209301458000_65.1.2401804.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2202819"},{"key":"2025010209301458000_65.1.2401804.2","doi-asserted-by":"publisher","DOI":"10.1177\/1479972317709649"},{"key":"2025010209301458000_65.1.2401804.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01567-2015"},{"key":"2025010209301458000_65.1.2401804.4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30053-5"},{"key":"2025010209301458000_65.1.2401804.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2025010209301458000_65.1.2401804.6","doi-asserted-by":"publisher","DOI":"10.1038\/nri1841"},{"key":"2025010209301458000_65.1.2401804.7","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201506-361OT"},{"key":"2025010209301458000_65.1.2401804.8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/293053"},{"key":"2025010209301458000_65.1.2401804.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301725"},{"key":"2025010209301458000_65.1.2401804.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00303-2019"},{"key":"2025010209301458000_65.1.2401804.11","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.20.4.3371"},{"key":"2025010209301458000_65.1.2401804.12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01489487","article-title":"Presence, activities, and molecular forms of cathepsin G, elastase, \u03b11-antitrypsin, and \u03b11-antichymotrypsin in bronchiectasis","volume":"244","author":"Sepper","year":"1995","journal-title":"J Clin Immunol"},{"key":"2025010209301458000_65.1.2401804.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.12.009"},{"key":"2025010209301458000_65.1.2401804.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00194611"},{"key":"2025010209301458000_65.1.2401804.15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105492"},{"key":"2025010209301458000_65.1.2401804.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.02.009"},{"key":"2025010209301458000_65.1.2401804.17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7277"},{"key":"2025010209301458000_65.1.2401804.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.05.011"},{"key":"2025010209301458000_65.1.2401804.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021713"},{"key":"2025010209301458000_65.1.2401804.20","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00151-2024"},{"key":"2025010209301458000_65.1.2401804.21","unstructured":"ClinicalTrials.gov. A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis (ASPEN). Date last updated: 24 March 2024. Date last accessed: 5 September 2024. https:\/\/clinicaltrials.gov\/study\/NCT04594369"},{"key":"2025010209301458000_65.1.2401804.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01551-2024"},{"key":"2025010209301458000_65.1.2401804.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1889OC"},{"key":"2025010209301458000_65.1.2401804.24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/CCIDE.S76080","article-title":"Papillon\u2013Lef\u00e8vre syndrome: clinical presentation and management options","volume":"7","author":"Sreeramulu","year":"2015","journal-title":"Clin Cosmet Investig Dent"},{"key":"2025010209301458000_65.1.2401804.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50747-6"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01804-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:09:50Z","timestamp":1740380990000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01804-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,2]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1183\/13993003.01804-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01804-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}